Source: mdmag.com A new machine-learning model can predict response to hypomethylating agents in patients with myelodysplastic syndromes, according to new research presented at the American Society of Hematology (ASH) 2019 Annual Meeting in Orlando. Investigators from the Cleveland Clinic developed a clinical artificial intelligence (AI) model to predict response and resistance to hypomethylating agents after Read More
Tag: MDS
Upgrade & Secure Your Future with DevOps, SRE, DevSecOps, MLOps!
We spend hours on Instagram and YouTube and waste money on coffee and fast food, but won’t spend 30 minutes a day learning skills to boost our careers.
Master in DevOps, SRE, DevSecOps & MLOps!
Learn from Guru Rajesh Kumar and double your salary in just one year.